3.連結財務諸表及び主な注記
(1)連結貸借対照表
| | (単位:千円) |
| 前連結会計年度 (2024年6月30日) | 当連結会計年度 (2025年6月30日) |
資産の部 | | |
流動資産 | | |
現金及び預金 | 13,954,886 | 14,919,028 |
受取手形 | 118,293 | 19,174 |
売掛金 | 3,682,650 | 3,555,953 |
電子記録債権 | 4,603,600 | 4,546,823 |
商品及び製品 | 1,151,024 | 2,124,094 |
仕掛品 | 534,249 | 540,924 |
原材料及び貯蔵品 | 580,985 | 599,763 |
その他 | 149,505 | 221,905 |
流動資産合計 | 24,775,196 | 26,527,666 |
固定資産 | | |
有形固定資産 | | |
建物及び構築物 | 5,655,516 | 5,654,060 |
減価償却累計額 | △2,548,576 | △2,748,896 |
建物及び構築物(純額) | 3,106,939 | 2,905,164 |
機械装置及び運搬具 | 3,844,307 | 3,870,459 |
減価償却累計額 | △2,662,715 | △2,958,177 |
機械装置及び運搬具(純額) | 1,181,592 | 912,281 |
工具、器具及び備品 | 1,474,651 | 1,530,744 |
減価償却累計額 | △1,167,010 | △1,200,143 |
工具、器具及び備品(純額) | 307,641 | 330,600 |
土地 | 1,761,774 | 1,807,189 |
建設仮勘定 | 477,884 | 3,240,308 |
有形固定資産合計 | 6,835,831 | 9,195,544 |
無形固定資産 | | |
その他 | 11,951 | 8,661 |
無形固定資産合計 | 11,951 | 8,661 |
投資その他の資産 | | |
投資有価証券 | 101,074 | 89,928 |
繰延税金資産 | 244,189 | 263,690 |
退職給付に係る資産 | 23,168 | 17,490 |
その他 | 12,603 | 11,776 |
投資その他の資産合計 | 381,036 | 382,886 |
固定資産合計 | 7,228,819 | 9,587,091 |
資産合計 | 32,004,016 | 36,114,758 |
| | (単位:千円) |
| 前連結会計年度 (2024年6月30日) | 当連結会計年度 (2025年6月30日) |
負債の部 | | |
流動負債 | | |
支払手形及び買掛金 | 1,486,785 | 1,567,463 |
電子記録債務 | 718,626 | 448,935 |
未払金 | 259,644 | 361,305 |
設備関係未払金 | 59,738 | 1,277,390 |
短期借入金 | 860,000 | 860,000 |
1年内返済予定の長期借入金 | 373,904 | 349,904 |
未払法人税等 | 731,912 | 1,039,296 |
賞与引当金 | 46,676 | 47,964 |
その他 | 439,660 | 411,420 |
流動負債合計 | 4,976,949 | 6,363,679 |
固定負債 | | |
長期借入金 | 1,591,384 | 1,241,480 |
繰延税金負債 | 1,129 | 7,192 |
役員退職慰労引当金 | 151,137 | 162,767 |
退職給付に係る負債 | 152,557 | 146,049 |
その他 | 79,183 | 72,925 |
固定負債合計 | 1,975,392 | 1,630,414 |
負債合計 | 6,952,341 | 7,994,094 |
純資産の部 | | |
株主資本 | | |
資本金 | 1,338,752 | 1,338,752 |
資本剰余金 | 1,022,303 | 1,022,303 |
利益剰余金 | 22,643,004 | 25,733,458 |
自己株式 | △407 | △484 |
株主資本合計 | 25,003,652 | 28,094,029 |
その他の包括利益累計額 | | |
その他有価証券評価差額金 | 41,470 | 30,798 |
繰延ヘッジ損益 | 6,552 | △4,163 |
その他の包括利益累計額合計 | 48,022 | 26,634 |
純資産合計 | 25,051,674 | 28,120,664 |
負債純資産合計 | 32,004,016 | 36,114,758 |
E3407192730コーア商事ホールディングス株式会社KOA SHOJI HOLDINGS CO.,LTD.通期第1号参考様式 [日本基準](連結)Japan GAAPtrueCTECTE2024-07-012025-06-30FY2025-06-302023-07-012024-06-302024-06-301falsefalsefalse927302023-06-30jppfs_cor:DeferredGainsOrLossesOnHedgesMember927302023-06-30jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember927302023-06-30jppfs_cor:ShareholdersEquityMember927302023-06-30jppfs_cor:TreasuryStockMember927302023-06-30jppfs_cor:RetainedEarningsMember927302023-06-30jppfs_cor:CapitalSurplusMember927302023-06-30jppfs_cor:CapitalStockMember927302025-06-30jppfs_cor:ValuationAndTranslationAdjustmentsMember927302025-06-30jppfs_cor:DeferredGainsOrLossesOnHedgesMember927302025-06-30jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember927302025-06-30jppfs_cor:ShareholdersEquityMember927302025-06-30jppfs_cor:TreasuryStockMember927302025-06-30jppfs_cor:RetainedEarningsMember927302025-06-30jppfs_cor:CapitalSurplusMember927302025-06-30jppfs_cor:CapitalStockMember927302024-07-012025-06-30jppfs_cor:ValuationAndTranslationAdjustmentsMember927302024-07-012025-06-30jppfs_cor:DeferredGainsOrLossesOnHedgesMember927302024-07-012025-06-30jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember927302024-07-012025-06-30jppfs_cor:ShareholdersEquityMember927302024-07-012025-06-30jppfs_cor:TreasuryStockMember927302024-07-012025-06-30jppfs_cor:RetainedEarningsMember927302024-07-012025-06-30jppfs_cor:CapitalSurplusMember927302024-07-012025-06-30jppfs_cor:CapitalStockMember927302024-06-30jppfs_cor:ValuationAndTranslationAdjustmentsMember927302024-06-30jppfs_cor:DeferredGainsOrLossesOnHedgesMember927302024-06-30jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember927302024-06-30jppfs_cor:ShareholdersEquityMember927302024-06-30jppfs_cor:TreasuryStockMember927302024-06-30jppfs_cor:RetainedEarningsMember927302024-06-30jppfs_cor:CapitalSurplusMember927302024-06-30jppfs_cor:CapitalStockMember927302023-07-012024-06-30jppfs_cor:ValuationAndTranslationAdjustmentsMember927302023-07-012024-06-30jppfs_cor:DeferredGainsOrLossesOnHedgesMember927302023-07-012024-06-30jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember927302023-07-012024-06-30jppfs_cor:ShareholdersEquityMember927302023-07-012024-06-30jppfs_cor:TreasuryStockMember927302023-07-012024-06-30jppfs_cor:RetainedEarningsMember927302023-07-012024-06-30jppfs_cor:CapitalSurplusMember927302023-07-012024-06-30jppfs_cor:CapitalStockMember927302023-06-30jppfs_cor:ValuationAndTranslationAdjustmentsMember927302025-08-08927302025-06-30927302024-07-012025-06-30927302024-06-30927302023-07-012024-06-30927302023-06-30927302025-06-30jpcrp_cor:ReportableSegmentsMember927302024-07-012025-06-30jpcrp_cor:ReportableSegmentsMember927302024-06-30jpcrp_cor:ReportableSegmentsMember927302023-07-012024-06-30jpcrp_cor:ReportableSegmentsMember927302025-06-30tse-acedjpfr-92730:DrugSubstanceSalesBusinessReportableSegmentsMember927302025-06-30tse-acedjpfr-92730:PharmaceuticalMarketingBusinessReportableSegmentsMember927302025-06-30jpcrp_cor:ReconcilingItemsMember927302024-07-012025-06-30tse-acedjpfr-92730:DrugSubstanceSalesBusinessReportableSegmentsMember927302024-07-012025-06-30tse-acedjpfr-92730:PharmaceuticalMarketingBusinessReportableSegmentsMember927302024-07-012025-06-30jpcrp_cor:ReconcilingItemsMember927302024-06-30tse-acedjpfr-92730:DrugSubstanceSalesBusinessReportableSegmentsMember927302024-06-30tse-acedjpfr-92730:PharmaceuticalMarketingBusinessReportableSegmentsMember927302024-06-30jpcrp_cor:ReconcilingItemsMember927302023-07-012024-06-30tse-acedjpfr-92730:DrugSubstanceSalesBusinessReportableSegmentsMember927302023-07-012024-06-30tse-acedjpfr-92730:PharmaceuticalMarketingBusinessReportableSegmentsMember927302023-07-012024-06-30jpcrp_cor:ReconcilingItemsMemberxbrli:pureiso4217:JPY